Global Primary Hyperoxaluria Treatment Market Research Report 2024(Status and Outlook)

Global Primary Hyperoxaluria Treatment Market Research Report 2024(Status and Outlook)



Report Overview:

Primary Hyperoxaluria (PH) is a rare genetic disorder caused by deficiencies in glyoxylate metabolism leading to oxalate deposition primarily in kidneys causing end-stage renal disease. It is an inherited autosomal recessive disorder and can be of three types based on the different responsible genes: type 1 (AGXT) (PH-I), type 2 (GRHPR) (PH-II), and type 3 (HOGA1) (PH-III). Signs and symptoms may include recurrent kidney stones, hematuria, and urinary tract infections (UTIs).

The Global Primary Hyperoxaluria Treatment Market Size was estimated at USD 667.39 million in 2023 and is projected to reach USD 920.23 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.

This report provides a deep insight into the global Primary Hyperoxaluria Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Primary Hyperoxaluria Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Primary Hyperoxaluria Treatment market in any manner.

Global Primary Hyperoxaluria Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Oxthera

Dicerna Pharmaceuticals

Allena Pharmaceuticals

Biocodex

Alnylam Pharmaceuticals

Tecoland Corporation

Zhejiang Tianxin Pharmaceutical

Takeda Pharmaceuticals

Wuxi Further Pharmaceutical

Market Segmentation (by Type)

Oral

Intravenous

Others

Market Segmentation (by Application)

Type 1

Type 2

Type 3

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Primary Hyperoxaluria Treatment Market
  • Overview of the regional outlook of the Primary Hyperoxaluria Treatment Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Primary Hyperoxaluria Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Primary Hyperoxaluria Treatment
1.2 Key Market Segments
1.2.1 Primary Hyperoxaluria Treatment Segment by Type
1.2.2 Primary Hyperoxaluria Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Primary Hyperoxaluria Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Primary Hyperoxaluria Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Primary Hyperoxaluria Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Primary Hyperoxaluria Treatment Market Competitive Landscape
3.1 Global Primary Hyperoxaluria Treatment Sales by Manufacturers (2019-2024)
3.2 Global Primary Hyperoxaluria Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Primary Hyperoxaluria Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Primary Hyperoxaluria Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Primary Hyperoxaluria Treatment Sales Sites, Area Served, Product Type
3.6 Primary Hyperoxaluria Treatment Market Competitive Situation and Trends
3.6.1 Primary Hyperoxaluria Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Primary Hyperoxaluria Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Primary Hyperoxaluria Treatment Industry Chain Analysis
4.1 Primary Hyperoxaluria Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Primary Hyperoxaluria Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Primary Hyperoxaluria Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Primary Hyperoxaluria Treatment Sales Market Share by Type (2019-2024)
6.3 Global Primary Hyperoxaluria Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Primary Hyperoxaluria Treatment Price by Type (2019-2024)
7 Primary Hyperoxaluria Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Primary Hyperoxaluria Treatment Market Sales by Application (2019-2024)
7.3 Global Primary Hyperoxaluria Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Primary Hyperoxaluria Treatment Sales Growth Rate by Application (2019-2024)
8 Primary Hyperoxaluria Treatment Market Segmentation by Region
8.1 Global Primary Hyperoxaluria Treatment Sales by Region
8.1.1 Global Primary Hyperoxaluria Treatment Sales by Region
8.1.2 Global Primary Hyperoxaluria Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Primary Hyperoxaluria Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Primary Hyperoxaluria Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Primary Hyperoxaluria Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Primary Hyperoxaluria Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Primary Hyperoxaluria Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Oxthera
9.1.1 Oxthera Primary Hyperoxaluria Treatment Basic Information
9.1.2 Oxthera Primary Hyperoxaluria Treatment Product Overview
9.1.3 Oxthera Primary Hyperoxaluria Treatment Product Market Performance
9.1.4 Oxthera Business Overview
9.1.5 Oxthera Primary Hyperoxaluria Treatment SWOT Analysis
9.1.6 Oxthera Recent Developments
9.2 Dicerna Pharmaceuticals
9.2.1 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Basic Information
9.2.2 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Product Overview
9.2.3 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Product Market Performance
9.2.4 Dicerna Pharmaceuticals Business Overview
9.2.5 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment SWOT Analysis
9.2.6 Dicerna Pharmaceuticals Recent Developments
9.3 Allena Pharmaceuticals
9.3.1 Allena Pharmaceuticals Primary Hyperoxaluria Treatment Basic Information
9.3.2 Allena Pharmaceuticals Primary Hyperoxaluria Treatment Product Overview
9.3.3 Allena Pharmaceuticals Primary Hyperoxaluria Treatment Product Market Performance
9.3.4 Allena Pharmaceuticals Primary Hyperoxaluria Treatment SWOT Analysis
9.3.5 Allena Pharmaceuticals Business Overview
9.3.6 Allena Pharmaceuticals Recent Developments
9.4 Biocodex
9.4.1 Biocodex Primary Hyperoxaluria Treatment Basic Information
9.4.2 Biocodex Primary Hyperoxaluria Treatment Product Overview
9.4.3 Biocodex Primary Hyperoxaluria Treatment Product Market Performance
9.4.4 Biocodex Business Overview
9.4.5 Biocodex Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Basic Information
9.5.2 Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Product Overview
9.5.3 Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Tecoland Corporation
9.6.1 Tecoland Corporation Primary Hyperoxaluria Treatment Basic Information
9.6.2 Tecoland Corporation Primary Hyperoxaluria Treatment Product Overview
9.6.3 Tecoland Corporation Primary Hyperoxaluria Treatment Product Market Performance
9.6.4 Tecoland Corporation Business Overview
9.6.5 Tecoland Corporation Recent Developments
9.7 Zhejiang Tianxin Pharmaceutical
9.7.1 Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Basic Information
9.7.2 Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Product Overview
9.7.3 Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Product Market Performance
9.7.4 Zhejiang Tianxin Pharmaceutical Business Overview
9.7.5 Zhejiang Tianxin Pharmaceutical Recent Developments
9.8 Takeda Pharmaceuticals
9.8.1 Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Basic Information
9.8.2 Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Product Overview
9.8.3 Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Product Market Performance
9.8.4 Takeda Pharmaceuticals Business Overview
9.8.5 Takeda Pharmaceuticals Recent Developments
9.9 Wuxi Further Pharmaceutical
9.9.1 Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Basic Information
9.9.2 Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Product Overview
9.9.3 Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Product Market Performance
9.9.4 Wuxi Further Pharmaceutical Business Overview
9.9.5 Wuxi Further Pharmaceutical Recent Developments
10 Primary Hyperoxaluria Treatment Market Forecast by Region
10.1 Global Primary Hyperoxaluria Treatment Market Size Forecast
10.2 Global Primary Hyperoxaluria Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Primary Hyperoxaluria Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Primary Hyperoxaluria Treatment Market Size Forecast by Region
10.2.4 South America Primary Hyperoxaluria Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Primary Hyperoxaluria Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Primary Hyperoxaluria Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Primary Hyperoxaluria Treatment by Type (2025-2030)
11.1.2 Global Primary Hyperoxaluria Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Primary Hyperoxaluria Treatment by Type (2025-2030)
11.2 Global Primary Hyperoxaluria Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Primary Hyperoxaluria Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Primary Hyperoxaluria Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings